Market Place
Sourcing Support
Akums launches Ripasudil + Timolol combo for glaucoma
02 Apr 2025 //
INDPHARMAPOST
Glenmark Pharma launches Vancomycin HCl for injection in US
02 Apr 2025 //
PR NEWSWIRE
Teva`s Schizophrenia Portfolio Enhanced by Ph 3 Trial Results
31 Mar 2025 //
GLOBENEWSWIRE
Nexus Pharmaceuticals Launches Fluorescein 2 mL
31 Mar 2025 //
BUSINESSWIRE
Aveva Drug Delivery (A DifGen company) gets FDA nod for Lidocaine
26 Mar 2025 //
PR NEWSWIRE
Cadila Launches Cadilose For Constipation, Hepatic Encephalopathy
25 Mar 2025 //
EXPRESSPHARMA
Journey Medical Launches Emrosi™ for Rosacea Treatment
24 Mar 2025 //
GLOBENEWSWIRE
Brazil`s Hypera to launch an Ozempic generic in 2026
22 Mar 2025 //
REUTERS
FDA Confirms Para IV Patent Litigation for Cosela Powder for Inj
21 Mar 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Zonisade Suspension
21 Mar 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Dyanavel XR Tablets
21 Mar 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Verquvo Tablets
21 Mar 2025 //
FDA
Hikma gets Health Canada approval for Kloxxado Nasal Spray 8 mg
20 Mar 2025 //
GLOBENEWSWIRE
ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets
19 Mar 2025 //
GLOBENEWSWIRE
Nexus Pharmaceuticals Launches Tranexamic Acid
19 Mar 2025 //
BUSINESSWIRE
MAIA Bio gets USAN Approval for "Ateganosine" as Anticancer Agent
19 Mar 2025 //
BUSINESSWIRE
USV launches: Empagliflozin and its combinations for diabetes care
18 Mar 2025 //
EXPRESSPHARMA
Zydus gets USFDA nod to produce prostate cancer treatment
18 Mar 2025 //
ECONOMICTIMES
Avenacy Launches Five Injectable Antibiotics in U.S. Market
17 Mar 2025 //
BUSINESSWIRE
Curia Expands Global Sterile Fill-Finish Network
17 Mar 2025 //
GLOBENEWSWIRE
NRx Pharmaceuticals Reports Q4 2024 Financial
17 Mar 2025 //
PR NEWSWIRE
Orion Corp: Disclosure Under Chapter 9 Section 10 Securities Mark
14 Mar 2025 //
GLOBENEWSWIRE
ANI Pharmaceuticals: FDA Approves ILUVIEN® Label Expansion
14 Mar 2025 //
GLOBENEWSWIRE
Glenmark Pharma launches Empagliflozin and combinations in India
13 Mar 2025 //
INDPHARMAPOST
Alkem launches generic empagliflozin & combinations in India
13 Mar 2025 //
INDPHARMAPOST
Alkem Launches Empagliflozin, Fixed Combos In India As Empanorm
12 Mar 2025 //
INDPHARMAPOST
Key diabetes drug price crashes by up to 90% as generics enter market
12 Mar 2025 //
BUSINESS STD
Glenmark Therapeutics launches Polyethylene Glycol 3350
11 Mar 2025 //
PR NEWSWIRE
Sunshine Bio Acquires Rights to Launch 2 Gastrointestinal Drugs
10 Mar 2025 //
ACCESSWIRE
$275 Million Settlement Benefits Consumers in Generic Drug Case
10 Mar 2025 //
PR NEWSWIRE
Zentiva Challenges Wastewater Directive To Protect Access
10 Mar 2025 //
PR NEWSWIRE
BDR Pharma Gets CDSCO Nod To Make Tucatinib Tablets
09 Mar 2025 //
MEDICALDIALOGUES
AstraZeneca approved to sell hyperkalaemia treatment in India
08 Mar 2025 //
ECONOMICTIMES
Curia Announces Strategic Refinancing to Support Continued Growth
07 Mar 2025 //
GLOBENEWSWIRE
Senores Pharma to acquire 14 ANDAs from Dr Reddy`s Laboratories
04 Mar 2025 //
ECONOMICTIMES
Reciprocal tariffs may make Indian generic drugs costlier in US
03 Mar 2025 //
ECONOMICTIMES
Glenmark USA Launches Acetylcysteine Injection 6g/30mL Vial
03 Mar 2025 //
PR NEWSWIRE
Glenmark launches Epinephrine injection in US
28 Feb 2025 //
ECONOMICTIMES
Veloxis Pharma`s VEL-101 Gets USAN Approval As Pegrizeprument
25 Feb 2025 //
PR NEWSWIRE
Currax Provides Update on Litigation Against Found Health
25 Feb 2025 //
PR NEWSWIRE
Marksans Pharma Arm Gets Nod for Ibuprofen, Paracetamol
25 Feb 2025 //
BUSINESS STD
CivicaScript® Lowers Price of its Generic Abiraterone Tablets
24 Feb 2025 //
PR NEWSWIRE
Vanda Pharma publishes for Charcot-Marie-Tooth disease type 2S
24 Feb 2025 //
PR NEWSWIRE
Teva & Alvotech Launch Selarsdi (Ustekinumab-Aekn) In The U.S.
21 Feb 2025 //
GLOBENEWSWIRE
FDA Confirms Para IV Patent Litigation for Norepinephrine Bitartrate
20 Feb 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Nuplazid
20 Feb 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Defitelio Injection
20 Feb 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Xtandi Tablets
20 Feb 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Tarpeyo Capsules
20 Feb 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Gemtesa Tablets
20 Feb 2025 //
FDA
Orion Corp.: Disclosure Under Chapter 9 Section 10 Securities Mar
19 Feb 2025 //
GLOBENEWSWIRE
Drugmakers Face Margin Loss Under Trump`s Tariff Plans
19 Feb 2025 //
ECONOMICTIMES
Amneal Launches Mesalamine, Gets FDA Nod For Lenalidomide
19 Feb 2025 //
BUSINESSWIRE
Teva Pharm CEO calls for faster US generic drug approvals
18 Feb 2025 //
REUTERS
Avenacy Announces Launch of Zoledronic Acid Injection
18 Feb 2025 //
BUSINESSWIRE
Aveva Launches Generic Fentanyl TDS, Third Complex TDS In 15M
17 Feb 2025 //
PR NEWSWIRE
Acquired approval for manufacture & marketing generic drugs
17 Feb 2025 //
PRESS RELEASE
Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution
14 Feb 2025 //
PR NEWSWIRE
Glenmark launches generic ophthalmic solution in US market
13 Feb 2025 //
ECONOMICTIMES
Glenmark launches Clindamycin Phosphate Foam
13 Feb 2025 //
BUSINESS STD
